{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:44Z","timestamp":1786997984214,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.virusres.2024.199448","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T15:01:20Z","timestamp":1725116480000},"page":"199448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["In vitro assessment of the anti-adenoviral activity of artemisinin and its derivatives"],"prefix":"10.1016","volume":"349","author":[{"given":"Diyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-6167","authenticated-orcid":false,"given":"Gen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.virusres.2024.199448_bib0033","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.00165-08","article-title":"The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice","volume":"52","author":"Bousejra-El Garah","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.virusres.2024.199448_bib0019","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acsinfecdis.0c00522","article-title":"Anti-SARS-CoV-2 potential of artemisinins in vitro","volume":"6","author":"Cao","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2024.199448_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.virusres.2024.199448_bib0018","doi-asserted-by":"crossref","unstructured":"D'Alessandro S., Scaccabarozzi D., Signorini L., Perego F., Ilboudo D.P., Ferrante P., et al. The use of antimalarial drugs against viral infection. Microorganisms. 2020;8(1):85.","DOI":"10.3390\/microorganisms8010085"},{"key":"10.1016\/j.virusres.2024.199448_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105034","article-title":"Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies","volume":"188","author":"Dodge","year":"2021","journal-title":"Antiviral Res."},{"issue":"6951","key":"10.1016\/j.virusres.2024.199448_bib0037","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein-Ludwig","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2024.199448_bib0042","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","article-title":"Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses","volume":"80","author":"Efferth","year":"2002","journal-title":"J. Mol. Med."},{"issue":"6","key":"10.1016\/j.virusres.2024.199448_bib0017","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Diseases"},{"issue":"1\u20132","key":"10.1016\/j.virusres.2024.199448_bib0039","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1, 2, 4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resistance Updates"},{"issue":"6","key":"10.1016\/j.virusres.2024.199448_bib0016","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"10","key":"10.1016\/j.virusres.2024.199448_bib0041","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1074\/jbc.M312893200","article-title":"RICK activates a NF-\u03baB-dependent anti-human cytomegalovirus response","volume":"279","author":"Eickhoff","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.virusres.2024.199448_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/QCO.0000000000000558","article-title":"Approach to infection and disease due to adenoviruses in solid organ transplantation","volume":"32","author":"Florescu","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virusres.2024.199448_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01002-20","article-title":"The FDA-approved drug nelfinavir inhibits lytic cell-free but not cell-associated nonlytic transmission of human adenovirus","volume":"64","author":"Georgi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.virusres.2024.199448_bib0038","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bcp.2008.10.015","article-title":"Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent","volume":"77","author":"Hartwig","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.virusres.2024.199448_bib0007","first-page":"2033","article-title":"Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant","volume":"129","author":"Hiwarkar","year":"2017","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.virusres.2024.199448_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7883\/yoken1952.47.157","article-title":"A simple and efficient method for purification of infectious recombinant adenovirus","volume":"47","author":"Kanegae","year":"1994","journal-title":"Japanese J. Med. Sci. Biol."},{"issue":"11","key":"10.1016\/j.virusres.2024.199448_bib0022","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/JCM.43.11.5509-5514.2005","article-title":"Rapid identification of human adenovirus types 3 and 7 from respiratory specimens via multiplex type-specific PCR","volume":"43","author":"Lee","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2024.199448_bib0021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fvl-2023-0001","article-title":"Kuwanon X from mulberry leaves exhibits antiviral activity against human adenoviruses","volume":"18","author":"Li","year":"2023","journal-title":"Future Virol."},{"key":"10.1016\/j.virusres.2024.199448_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197886","article-title":"Infection and replication of human adenovirus type 3 possessing type 5 fiber protein in rodent cells","volume":"279","author":"Liu","year":"2020","journal-title":"Virus Res."},{"issue":"7","key":"10.1016\/j.virusres.2024.199448_bib0005","doi-asserted-by":"crossref","first-page":"e13769","DOI":"10.1111\/petr.13769","article-title":"Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: a case series","volume":"24","author":"Londeree","year":"2020","journal-title":"Pediatr. TransPlant"},{"key":"10.1016\/j.virusres.2024.199448_bib0004","series-title":"Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment. Seminars in Respiratory and Critical Care Medicine","author":"Lynch III","year":"2021"},{"key":"10.1016\/j.virusres.2024.199448_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2018.09.011","article-title":"Inhibition of adenovirus infection by mifepristone","volume":"159","author":"Marrugal-Lorenzo","year":"2018","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2024.199448_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ddr.20344","article-title":"Artemisinin antimalarials: preserving the \u201cmagic bullet\u201d","volume":"71","author":"Maude","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.virusres.2024.199448_bib0034","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-2952(94)90287-9","article-title":"Alkylation of proteins by artemisinin","volume":"48","author":"Meshnick","year":"1994","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.virusres.2024.199448_bib0015","doi-asserted-by":"crossref","unstructured":"Nosten F., White N.J. Artemisinin-based combination treatment of falciparum malaria. Defining and defeating the intolerable burden of Malaria III: progress and perspectives: supplement to volume 77 (6) of American journal of tropical medicine and hygiene. 2007.","DOI":"10.4269\/ajtmh.2007.77.iii"},{"issue":"8","key":"10.1016\/j.virusres.2024.199448_bib0030","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/AAC.00471-09","article-title":"Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum","volume":"53","author":"Obaldia","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.virusres.2024.199448_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00288-18","article-title":"The artemisinin derivative artemisone is a potent inhibitor of human cytomegalovirus replication","volume":"62","author":"Oiknine-Djian","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2024.199448_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104716","article-title":"Human adenovirus species in children with acute respiratory illnesses","volume":"134","author":"Probst","year":"2021","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2024.199448_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"38","key":"10.1016\/j.virusres.2024.199448_bib0032","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1073\/pnas.0500972102","article-title":"The antimalarial drug artemisinin alkylates heme in infected mice","volume":"102","author":"Robert","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.virusres.2024.199448_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8091284","article-title":"Recent advances in novel antiviral therapies against human adenovirus","volume":"8","author":"Saha","year":"2020","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.virusres.2024.199448_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002549","article-title":"Transcriptional activation of the adenoviral genome is mediated by capsid protein VI","volume":"8","author":"Schreiner","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2024.199448_bib0001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bj.2021.08.009","article-title":"Human adenovirus infections in pediatric population-an update on clinico\u2013pathologic correlation","volume":"45","author":"Shieh","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.virusres.2024.199448_bib0010","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.virusres.2024.199448_bib0003","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijregi.2021.10.001","article-title":"Morbidity burden, seasonality and factors associated with the human respiratory syncytial virus, human parainfluenza virus, and human adenovirus infections in Kenya","volume":"1","author":"Umuhoza","year":"2021","journal-title":"IJID Reg."},{"issue":"4","key":"10.1016\/j.virusres.2024.199448_bib0024","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.72.4.3455-3458.1998","article-title":"Adenovirus internalization and infection require dynamin","volume":"72","author":"Wang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199448_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104810","article-title":"Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production","volume":"179","author":"Wang","year":"2020","journal-title":"Antiviral Res."},{"issue":"10","key":"10.1016\/j.virusres.2024.199448_bib0036","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0960-894X(03)00293-2","article-title":"Study on the mechanism of action of artemether against schistosomes: the identification of cysteine adducts of both carbon-centred free radicals derived from artemether","volume":"13","author":"Wu","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.virusres.2024.199448_bib0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0006-2952(93)90425-V","article-title":"Alkylation of human albumin by the antimalarial artemisinin","volume":"46","author":"Ying-Zi","year":"1993","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.virusres.2024.199448_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bcp.2009.04.014","article-title":"Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells","volume":"78","author":"Youns","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.virusres.2024.199448_bib0023","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/fvl-2021-0087","article-title":"The novel antiviral properties of brassicasterol against human adenovirus","volume":"16","author":"Yu","year":"2021","journal-title":"Future Virol."},{"key":"10.1016\/j.virusres.2024.199448_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154259","article-title":"Artesunate: a review of its therapeutic insights in respiratory diseases","volume":"104","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.virusres.2024.199448_bib0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2007.02.013","article-title":"How adenovirus strives to control cellular gene expression","volume":"363","author":"Zhao","year":"2007","journal-title":"Virology"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T18:50:03Z","timestamp":1726771803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170224001412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":43,"alternative-id":["S0168170224001412"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199448","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assessment of the anti-adenoviral activity of artemisinin and its derivatives","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199448"}}